These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 11517264)
1. p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. Ko J; Humbert S; Bronson RT; Takahashi S; Kulkarni AB; Li E; Tsai LH J Neurosci; 2001 Sep; 21(17):6758-71. PubMed ID: 11517264 [TBL] [Abstract][Full Text] [Related]
2. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses. Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169 [TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinase 5 activators p35 and p39 facilitate formation of functional synapses. Johansson JU; Lilja L; Chen XL; Higashida H; Meister B; Noda M; Zhong ZG; Yokoyama S; Berggren PO; Bark C Brain Res Mol Brain Res; 2005 Aug; 138(2):215-27. PubMed ID: 15908038 [TBL] [Abstract][Full Text] [Related]
4. The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner. Dhavan R; Greer PL; Morabito MA; Orlando LR; Tsai LH J Neurosci; 2002 Sep; 22(18):7879-91. PubMed ID: 12223541 [TBL] [Abstract][Full Text] [Related]
5. Synergistic contributions of cyclin-dependant kinase 5/p35 and Reelin/Dab1 to the positioning of cortical neurons in the developing mouse brain. Ohshima T; Ogawa M; Veeranna ; Hirasawa M; Longenecker G; Ishiguro K; Pant HC; Brady RO; Kulkarni AB; Mikoshiba K Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2764-9. PubMed ID: 11226314 [TBL] [Abstract][Full Text] [Related]
6. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator. Hisanaga S; Saito T Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209 [TBL] [Abstract][Full Text] [Related]
7. Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene. Patzke H; Maddineni U; Ayala R; Morabito M; Volker J; Dikkes P; Ahlijanian MK; Tsai LH J Neurosci; 2003 Apr; 23(7):2769-78. PubMed ID: 12684463 [TBL] [Abstract][Full Text] [Related]
8. Cyclin-dependent kinase 5 associated with p39 promotes Munc18-1 phosphorylation and Ca(2+)-dependent exocytosis. Lilja L; Johansson JU; Gromada J; Mandic SA; Fried G; Berggren PO; Bark C J Biol Chem; 2004 Jul; 279(28):29534-41. PubMed ID: 15123626 [TBL] [Abstract][Full Text] [Related]
9. p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair. Bankston AN; Li W; Zhang H; Ku L; Liu G; Papa F; Zhao L; Bibb JA; Cambi F; Tiwari-Woodruff SK; Feng Y J Biol Chem; 2013 Jun; 288(25):18047-57. PubMed ID: 23645679 [TBL] [Abstract][Full Text] [Related]
10. Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system. Zheng M; Leung CL; Liem RK J Neurobiol; 1998 May; 35(2):141-59. PubMed ID: 9581970 [TBL] [Abstract][Full Text] [Related]
11. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice. Hallows JL; Chen K; DePinho RA; Vincent I J Neurosci; 2003 Nov; 23(33):10633-44. PubMed ID: 14627648 [TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner. Asada A; Saito T; Hisanaga S J Cell Sci; 2012 Jul; 125(Pt 14):3421-9. PubMed ID: 22467861 [TBL] [Abstract][Full Text] [Related]
13. Mutant superoxide dismutase 1 causes motor neuron degeneration independent of cyclin-dependent kinase 5 activation by p35 or p25. Takahashi S; Kulkarni AB J Neurochem; 2004 Mar; 88(5):1295-304. PubMed ID: 15009685 [TBL] [Abstract][Full Text] [Related]
15. Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35. Yamada M; Saito T; Sato Y; Kawai Y; Sekigawa A; Hamazumi Y; Asada A; Wada M; Doi H; Hisanaga SI J Neurochem; 2007 Sep; 102(5):1477-1487. PubMed ID: 17394551 [TBL] [Abstract][Full Text] [Related]
16. Structural basis for the different stability and activity between the Cdk5 complexes with p35 and p39 activators. Saito T; Yano M; Kawai Y; Asada A; Wada M; Doi H; Hisanaga SI J Biol Chem; 2013 Nov; 288(45):32433-32439. PubMed ID: 24085300 [TBL] [Abstract][Full Text] [Related]
17. p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton. Humbert S; Dhavan R; Tsai L J Cell Sci; 2000 Mar; 113 ( Pt 6)():975-83. PubMed ID: 10683146 [TBL] [Abstract][Full Text] [Related]
18. Synaptic localization of p39, a neuronal activator of cdk5. Humbert S; Lanier LM; Tsai LH Neuroreport; 2000 Jul; 11(10):2213-6. PubMed ID: 10923673 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5. Kobayashi H; Saito T; Sato K; Furusawa K; Hosokawa T; Tsutsumi K; Asada A; Kamada S; Ohshima T; Hisanaga S J Biol Chem; 2014 Jul; 289(28):19627-36. PubMed ID: 24872417 [TBL] [Abstract][Full Text] [Related]